Linvesta EMP 25mg/5mg Tablets
Pay in 3 Installments of
Rs.
268
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Linvesta EMP 25mg/5mg Tablets contain Empagliflozin 25mg and Linagliptin 5mg — a high-dose fixed combination for adults with Type 2 diabetes who need more intensive glycaemic control. Empagliflozin 25mg provides greater urinary glucose excretion and blood pressure reduction, while Linagliptin 5mg enhances pancreatic insulin response in a glucose-dependent manner, minimising hypoglycaemia risk.
At the 25mg empagliflozin dose, additional cardiorenal protective effects are observed, making this combination appropriate for patients with established cardiovascular disease or at high cardiovascular risk who also need to lower HbA1c. It is typically used as add-on or maintenance therapy following dose optimisation.
Side effects are similar to the lower-dose formulation: urinary and genital infections, mild dehydration, and a small risk of diabetic ketoacidosis. Patients should stay well hydrated and report any unusual symptoms promptly to their physician.
Buy Linvesta EMP 25mg/5mg from Derma.pk — Pakistan's trusted licensed pharmacy. See our General Medicines collection. A valid prescription is required. Email sales@derma.pk or WhatsApp +92-320-5999650 for order assistance and nationwide delivery.
Usage & Benefits
- Higher Empagliflozin 25mg dose for more intensive HbA1c reduction
- SGLT2 inhibition reduces blood pressure and body weight alongside glucose
- Proven cardiorenal benefits: reduces cardiovascular death and progression of chronic kidney disease
- Linagliptin 5mg adds glucose-dependent insulin enhancement with low hypoglycaemia risk
- Single daily tablet simplifies dual-class diabetes therapy
How To Use
Use only as directed by your healthcare provider.
1. Take one tablet once daily, with or without food, preferably at the same time each day.
2. Swallow whole with a glass of water; do not crush or chew.
3. Maintain adequate fluid intake to prevent dehydration.
4. Monitor kidney function, blood pressure, and blood glucose as scheduled by your physician.
5. Consult your doctor before adjusting dose or stopping the medication.
FAQs
What is the difference between Linvesta EMP 10mg/5mg and 25mg/5mg?
The 25mg formulation contains a higher dose of Empagliflozin, providing greater glucose-lowering, blood pressure-lowering, and cardiorenal protective effects.
Who should take Linvesta EMP 25mg/5mg?
It is indicated for adults with Type 2 diabetes, particularly those at high cardiovascular risk or with established cardiovascular or renal disease. A doctor's prescription is required.
Is diabetic ketoacidosis a risk with Empagliflozin?
DKA is a rare but serious risk, including in patients with near-normal glucose (euglycaemic DKA). Seek emergency care if you experience nausea, vomiting, abdominal pain, or fatigue, even if glucose appears acceptable.
